Ireland
--:--IST
Active, not recruiting Not applicable

Examining the Effects of Theory-based Education on Individuals' Sexual Behavior.

NCT07145749 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-07
Last updated
2025-08-28

Condition(s) studied

HIV InfectionsSexual Behavior

Investigational drug(s) / intervention(s)

Transtheoretical theory-based educationPre-test-after-test-re-test

Transtheoretical theory-based education: Transtheoretical theory-based education will be provided to individuals with substance use disorders face-to-face in 8 modes and each lesson will last 45 minutes. Weekly education stages of transtheoretical theory-based education: Week 1; Stage 1 (not thinking); Weeks 2 and 3, Stage 2 (Thinking/Intention); Weeks 4 and 5, Stage 3 (Preparation); Weeks 6 and 7, Stage 4 (taking action); Week 8, Stage 5 (Maintenance/Continuing).

Pre-test-after-test-re-test: Information Form, Sexual Risk Taking Scale, AIDS Knowledge Scale and AIDS Prevention Self-Efficacy Scale

Study summary

The research was planned to examine the effect of the transtheoretic theory-based education given to individuals followed in AMATEM on their sexual risk-taking status, AIDS knowledge level and AIDS prevention self-efficacy.

Research Hypotheses H0: Transtheoretical theory-based education given to individuals followed in AMATEM has no effect on their sexual risk taking, AIDS knowledge level and protection self-efficacy.

H1-1: Transtheoretic theory-based education given to individuals followed in AMATEM has an effect on the level of sexual risk taking.

H1-2: The transtheoretic theory-based education given to individuals followed in AMATEM is A

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Willing to participate voluntarily in the study * Age 18 years or older * Under probation and receiving treatment at AMATEM * Able to read and write (literate) Exclusion Criteria: * Presence of visual, hearing, or communication disorders * Refusing to participate voluntarily in the study

Primary outcome measure(s)

  • Sexual Risk Taking Scale (SCRAS) — At the end of the planned training program (8 weeks); It will be applied as the final test. In order to measure the permanence of behavioral change after the training, the final test was planned to be repeated after an average of 2 months.
    It consists of a total of 10 items aimed at collecting information about risky sexual behaviors experienced by the person in the last 12 months and throughout his/her life. Five items of the scale are answered as yes-no, two items are answered as fill-in-the-blank, two items are answered as triple Likert type, and one item is answered as quadruple Likert type. The possible score from the scale is between 0 and 10, with higher scores indicating more sexual risk taking.The alpha internal consistency coefficient of the scale was found to be 0.71.
  • AIDS Knowledge Scale (AIS) — At the end of the planned training program (8 weeks); It will be applied as the final test. In order to measure the permanence of behavioral change after the training, the final test was planned to be repeated after an average of 2 months.
    The scale has 18 items. The total score varies between 0-18, with higher scores indicating more AIDS knowledge. The content validity index of the scale was found to be 0.98. The internal consistency of the scale was found to be 0.85 and the test-retest reliability was found to be 0.80.
  • AIDS Prevention Self-Efficacy Scale (AIPS) — At the end of the planned training program (8 weeks); It will be applied as the final test. In order to measure the permanence of behavioral change after the training, the final test was planned to be repeated after an average of 2 months.
    It is a five-point Likert-type scale with a total of 27 items. Scores on the scale range from 27 to 135, with higher scores indicating higher self-efficacy. The internal consistency coefficient of the total scale was found to be 0.93, and the test-retest reliability was found to be 0.85.

Trial sites (1)

FacilityCityRegionStatus
Sakarya Sağlik Bilimleri Enstitüsü Sakarya Serdi̇van
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07145749 on ClinicalTrials.gov ↗ ← All trials in Turkey